CareView Communications Reports 20% Revenue Growth to $2.85 Million in Q2 2026

CareView Communications, Inc. reported a total revenue of $2.85 million for the three months ended June 30, 2026, marking an increase of approximately 20% from $2.38 million in the same period of 2025. For the first half of 2026, the company generated $5.04 million in revenue, up from $4.62 million in the prior year, driven primarily by new customer sales. Despite the revenue growth, CareView recorded a net loss of $283,663 for the second quarter, a significant improvement from the $588,710 loss reported in the same quarter of 2025. The net loss for the first half of 2026 was $1.04 million, down from $1.51 million in the previous year.

Operating expenses for the second quarter of 2026 totaled $2.34 million, an increase from $2.18 million in the prior year, primarily due to higher product deployment costs and research and development expenses. Human resource costs decreased slightly, while other expenses rose due to increased R&D activities related to new software licenses. The company’s operating income for the second quarter was $506,967, compared to $198,771 in the same period last year, reflecting improved operational efficiency.

In terms of operational metrics, CareView has expanded its customer base, with installations in over 150 hospitals. The company continues to enhance its product offerings, including the CareView Patient Safety System, which integrates advanced video monitoring technology aimed at improving patient safety and reducing operational costs. The company has also seen increased usage of its SitterView and TeleMedView products, which facilitate remote patient monitoring, a response to growing demands in the healthcare sector.

As of June 30, 2026, CareView reported total assets of $5.90 million, up from $4.64 million at the end of 2025. However, the company also faced a working capital deficit of $44.29 million, primarily due to outstanding notes payable and accrued interest. Management has expressed concerns regarding the company's ability to continue as a going concern without additional funding, as the accumulated deficit reached $216.83 million. The company is exploring various avenues for financing, including increasing sales volumes and raising capital through debt or equity securities.

Looking ahead, CareView remains focused on expanding its market presence and enhancing its product offerings to meet the evolving needs of healthcare facilities. The company is committed to improving operational efficiencies and generating positive cash flows to support its growth strategy. However, management acknowledges the challenges posed by its current financial condition and the need for additional funding to sustain operations in the coming year.